Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 64 citing articles:

Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy
Matthias H. Tschöp, Rubén Nogueiras, Bo Åhrén
Diabetologia (2023) Vol. 66, Iss. 10, pp. 1796-1808
Open Access | Times Cited: 52
Peptides Derived from Soy and Lupin Protein as Dipeptidyl-Peptidase IV Inhibitors: In Vitro Biochemical Screening and in Silico Molecular Modeling Study
Carmen Lammi, Chiara Zanoni, Anna Arnoldi, et al.
Journal of Agricultural and Food Chemistry (2016) Vol. 64, Iss. 51, pp. 9601-9606
Open Access | Times Cited: 116
Soybean- and Lupin-Derived Peptides Inhibit DPP-IV Activity on In Situ Human Intestinal Caco-2 Cells and Ex Vivo Human Serum
Carmen Lammi, Carlotta Bollati, Simonetta Ferruzza, et al.
Nutrients (2018) Vol. 10, Iss. 8, pp. 1082-1082
Open Access | Times Cited: 97
DPP-4 Inhibition and the Path to Clinical Proof
Bo Åhrén
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 86
The role of avocado plant and its derivatives in the management of diabetes mellitus: a natural approach to glycemic control
Mary Olaoluwa Agunloye, Daniel Udofia Owu, Olufunke Onaadepo, et al.
Journal of Diabetes & Metabolic Disorders (2025) Vol. 24, Iss. 1
Closed Access | Times Cited: 1
Comparison of SGLT2 inhibitors with DPP-4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus
Young Sang Lyu, Seok Kyu Oh, Jin Hwa Kim, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 19
DPP-4 is expressed in human pancreatic beta cells and its direct inhibition improves beta cell function and survival in type 2 diabetes
Marco Bugliani, Farooq Syed, Flávia M. Paula, et al.
Molecular and Cellular Endocrinology (2018) Vol. 473, pp. 186-193
Closed Access | Times Cited: 59
A Novel Dipeptidyl Peptidase IV Inhibitory Tea Peptide Improves Pancreatic β-Cell Function and Reduces α-Cell Proliferation in Streptozotocin-Induced Diabetic Mice
Yating Lu, Peng Lü, Yu Wang, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 2, pp. 322-322
Open Access | Times Cited: 37
A Comprehensive Review and Perspective on Natural Sources as Dipeptidyl Peptidase-4 Inhibitors for Management of Diabetes
Sibhghatulla Shaikh, Eun Ju Lee, Khurshid Ahmad, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 6, pp. 591-591
Open Access | Times Cited: 29
Polyphenols-rich polyherbal mixture attenuates hepatorenal impairment, dyslipidaemia, oxidative stress and inflammation in alloxan-induced diabetic rats
Bilal Aslam, Asif Hussain, Zia ud Din Sindhu, et al.
Journal of Applied Animal Research (2023) Vol. 51, Iss. 1, pp. 515-523
Open Access | Times Cited: 11
Food-derived DPP4 inhibitors: Drug discovery based on high-throughput virtual screening and deep learning
Jiahua Tao, Liang Chen, Jiaqi Chen, et al.
Food Chemistry (2025) Vol. 477, pp. 143505-143505
Closed Access
Early Combination Therapy with Oral Glucose-Lowering Agents in Type 2 Diabetes
Cristina Bianchi, Giuseppe Daniele, Angela Dardano, et al.
Drugs (2017) Vol. 77, Iss. 3, pp. 247-264
Closed Access | Times Cited: 33
Effect of race on the glycaemic response to sitagliptin: Insights from the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
Timothy M. E. Davis, Hillary Mulder, Yuliya Lokhnygina, et al.
Diabetes Obesity and Metabolism (2018) Vol. 20, Iss. 6, pp. 1427-1434
Closed Access | Times Cited: 28
Relationship between diet/exercise and pharmacotherapy to enhance the GLP‐1 levels in type 2 diabetes
Yuki Fujiwara, Shunsuke Eguchi, H Murayama, et al.
Endocrinology Diabetes & Metabolism (2019) Vol. 2, Iss. 3
Open Access | Times Cited: 27
Small dense low-density lipoprotein-lowering agents
Shahin Alizadeh‐Fanalou, Ali Nazarizadeh, Fatemeh Alian, et al.
Biological Chemistry (2020) Vol. 401, Iss. 10, pp. 1101-1121
Closed Access | Times Cited: 21
MiR-34a-5p and miR-452-5p: The Novel Regulators of Pancreatic Endocrine Dysfunction in Diabetic Zucker Rats?
Tong Su, Jiejun Hou, Tonghua Liu, et al.
International Journal of Medical Sciences (2021) Vol. 18, Iss. 14, pp. 3171-3181
Open Access | Times Cited: 19
Thiazolidinedione as a Promising Medicinal Scaffold for the Treatment of Type 2 Diabetes
Gurvinder Singh, Rajesh Kumar, Desna D.S., et al.
Current Diabetes Reviews (2023) Vol. 20, Iss. 6
Closed Access | Times Cited: 8
Efficacy and safety of adding evogliptin versus sitagliptin for metformin‐treated patients with type 2 diabetes: A 24‐week randomized, controlled trial with open label extension
Sangmo Hong, Cheol‐Young Park, Dong‐Min Hwang, et al.
Diabetes Obesity and Metabolism (2017) Vol. 19, Iss. 5, pp. 654-663
Open Access | Times Cited: 24
Unexplained reciprocal regulation of diabetes and lipoproteins
Sei Higuchi, María C. Izquierdo, Rebecca A. Haeusler
Current Opinion in Lipidology (2018) Vol. 29, Iss. 3, pp. 186-193
Open Access | Times Cited: 21
Fibroblast activation protein is dispensable for control of glucose homeostasis and body weight in mice
Brandon L. Panaro, Andrew L. Coppage, Jacqueline L. Beaudry, et al.
Molecular Metabolism (2018) Vol. 19, pp. 65-74
Open Access | Times Cited: 21
Identification of novel uracil derivatives incorporating benzoic acid moieties as highly potent Dipeptidyl Peptidase-IV inhibitors
Junli Huang, Xiaoyan Deng, Siru Zhou, et al.
Bioorganic & Medicinal Chemistry (2019) Vol. 27, Iss. 4, pp. 644-654
Closed Access | Times Cited: 20
Antioxidative Potentials of Incretin‐Based Medications: A Review of Molecular Mechanisms
Habib Yaribeygi, Mina Maleki, Thozhukat Sathyapalan, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 17
Comparative safety for cardiovascular outcomes of DPP-4 inhibitors versus glimepiride in patients with type 2 diabetes
Hyouk-Jun Chin, Jin Hyun Nam, Eui‐Kyung Lee, et al.
Medicine (2017) Vol. 96, Iss. 25, pp. e7213-e7213
Open Access | Times Cited: 21
Ketosis-Prone Type 2 Diabetes: A Case Series
Åke Sjöholm
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 17
β-cell replenishment: Possible curative approaches for diabetes mellitus
Nirali Rathwa, Roma Patel, Sayantani Pramanik Palit, et al.
Nutrition Metabolism and Cardiovascular Diseases (2020) Vol. 30, Iss. 11, pp. 1870-1881
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top